The biology of lipoprotein(a): From genetics to molecular mechanisms
While environmental factors such as inflammation and hormonal status can transiently modulate levels, genetic variation overwhelmingly dictates lifelong Lp(a) burden. As novel agents targeting Lp(a) enter late-stage clinical trials, mechanistic insights into Lp(a) biology will be essential to risk stratification and future clinical management.
Authors
- Michelle B. Atallah (ORCID: https://orcid.org/0000-0003-0721-2180)
- Nadim Nasrallah
- Tarek Harb (ORCID: https://orcid.org/0000-0002-2573-5260)
- Gary Gerstenblith (ORCID: https://orcid.org/0000-0001-6046-6812)
- Thorsten M. Leucker (ORCID: https://orcid.org/0000-0003-2569-6617)
Institutions
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
Publication Details
- Journal
- European Journal of Clinical Investigation
- Published
- 2025-10-03
- DOI
- https://doi.org/10.1111/eci.70133
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00